11/08/2024 6:17 AM | Fulgent Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024 6:10 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2024 3:30 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:20 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/05/2024 3:21 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:21 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 6:36 PM | Fulgent Genetics (Subject) Kim Paul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 6:37 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024 5:33 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 5:33 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 5:33 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 5:34 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 7:22 PM | Fulgent Genetics (Subject) Hsieh Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024 6:38 AM | Fulgent Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024 6:09 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 3:27 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 3:28 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 3:29 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:22 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:22 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 5:04 PM | Fulgent Genetics (Issuer) Marsh Linda (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 5:05 PM | Fulgent Genetics (Issuer) GROVES REGINA E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 5:06 PM | Fulgent Genetics (Issuer) Nohaile Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:29 PM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:21 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:22 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 6:34 AM | Fulgent Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024 6:05 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 3:35 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 6:07 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting) Ming Hsieh Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:26 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:27 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:28 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:10 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:11 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:11 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:12 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:08 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Free Ebook shares Tesla’s roadmap to $500 a share (Ad) Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner.
In his professional opinion, the share price could reach $500 or more…
Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound.
In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now…
For the time being, he’s giving away his Tesla ebook for free.
Inside explains how shares could reach $500 in the near future. To claim your copy, follow this link |
02/27/2024 5:50 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:52 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:55 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:48 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 6:27 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 6:26 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:01 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:39 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:21 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:21 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:21 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 7:49 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 8:43 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 5:00 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:47 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:54 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 5:12 PM | Fulgent Genetics (Subject) Gao Hanlin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 5:12 PM | Fulgent Genetics (Subject) Kim Paul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 5:13 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023 3:27 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:30 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 8:21 PM | Fulgent Genetics (Subject) Kim Paul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 8:21 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |